Insignia Strategies
Insignia Strategies LLC is dedicated to helping pharmaceutical and biotech companies maximize the value of their portfolios through expert advice in product strategy, acquisition, development, regulatory approval, manufacturing, commercialization, and more. Their experienced team covers all aspects of the industry, including market research, medical education, and legal relationships, with a focus on delivering tailored solutions to grow and scale businesses in the pharmaceutical sector.
Industries
Nr. of Employees
small (1-50)
Insignia Strategies
Kansas City, Missouri, United States, North America
Services
Advisory services for product strategy, market entry, launch planning, and lifecycle optimization delivered as consulting engagements or virtual executive support.
Commercial assessment, target identification, negotiation support, diligence, and deal documentation for product transactions and licensing.
Regulatory planning and support including FDA meeting preparation, review of promotional materials, and strategy for approval pathways.
Protocol design and analysis support for pre-clinical and early-phase clinical studies.
Medical information, medical writing, publication planning, MSL integration, and safety monitoring support.
Consulting on formulation development and novel delivery approaches including transdermal, nanotechnology, ODTs and drug/device combinations.
Advisory services for product strategy, market entry, launch planning, and lifecycle optimization delivered as consulting engagements or virtual executive support.
Commercial assessment, target identification, negotiation support, diligence, and deal documentation for product transactions and licensing.
Regulatory planning and support including FDA meeting preparation, review of promotional materials, and strategy for approval pathways.
Protocol design and analysis support for pre-clinical and early-phase clinical studies.
Medical information, medical writing, publication planning, MSL integration, and safety monitoring support.
Consulting on formulation development and novel delivery approaches including transdermal, nanotechnology, ODTs and drug/device combinations.
Expertise Areas
- Commercial strategy and product lifecycle management
- Business development and M&A due diligence
- Regulatory strategy and submissions (including ANDA and 505(b)(2))
- Clinical trial design and early-phase development
Key Technologies
- Clinical trial design (Phase I and Phase IIa)
- Pharmacokinetics and pharmaceutical sciences
- Transdermal delivery systems
- Nanotechnology-enabled formulations
News & Updates
Managed the launch and commercialization of a substantial product for the treatment of Multiple Sclerosis
Grew the product to over $5B in sales and extended its market presence for over 20 years.
Developed and obtained regulatory approval, and marketed key products for various conditions
Including seasonal allergies, diabetes, Parkinson’s disease, cardiovascular disorders, and ulcers.
Grew a substantial respiratory brand portfolio
Through regulatory and marketing strategies.
Led efforts to take two major brand products over the counter
Transitioned key products to over-the-counter status.
Led business development efforts for sale and acquisition of products
Including the development of commercial strategies for deals.
Managed the launch and commercialization of a substantial product for the treatment of Multiple Sclerosis
Grew the product to over $5B in sales and extended its market presence for over 20 years.
Developed and obtained regulatory approval, and marketed key products for various conditions
Including seasonal allergies, diabetes, Parkinson’s disease, cardiovascular disorders, and ulcers.
Grew a substantial respiratory brand portfolio
Through regulatory and marketing strategies.
Led efforts to take two major brand products over the counter
Transitioned key products to over-the-counter status.
Led business development efforts for sale and acquisition of products
Including the development of commercial strategies for deals.